TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314507. A total of 30 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $103 | -46.1% | 623 | 0.0% | 0.00% | – |
| Q2 2020 | $191 | +31.7% | 623 | 0.0% | 0.00% | – |
| Q1 2020 | $145 | +19.8% | 623 | 0.0% | 0.00% | – |
| Q4 2019 | $121 | -1.6% | 623 | +36.6% | 0.00% | – |
| Q3 2019 | $123 | -78.9% | 456 | 0.0% | 0.00% | – |
| Q2 2019 | $584 | -28.1% | 456 | 0.0% | 0.00% | – |
| Q1 2019 | $812 | – | 456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 23,370 | $30,000 | 0.01% |
| A.R.T. Advisors, LLC | 69,645 | $89,000 | 0.01% |
| Virtu Financial LLC | 39,318 | $50,000 | 0.00% |
| Blume Capital Management, Inc. | 425 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 582,180 | $746,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 35 | $0 | 0.00% |
| UBS Group AG | 1,975 | $2,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
| Advisor Group, Inc. | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,125 | $8,000 | 0.00% |